Reversible skin telangiectasia induced by imatinib mesylate in chronic myeloid leukemia

Leuk Lymphoma. 2016 Nov;57(11):2731-2. doi: 10.3109/10428194.2016.1163346. Epub 2016 Apr 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Imatinib Mesylate / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Remission, Spontaneous
  • Skin Diseases / chemically induced*
  • Skin Diseases / pathology
  • Telangiectasis / chemically induced*
  • Telangiectasis / pathology
  • Withholding Treatment

Substances

  • Imatinib Mesylate